Related Experiment Video
Updated: May 12, 2026

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets
Published on: March 1, 2024
Full-Length Transcriptome Profiles Reveal the Molecular Function of Oncogene HNRNPA2B1 in Triple-Negative Breast
Lina Yi1, Yongtao Li1, Jianghua Ou1
1Department of Breast Surgery, Xinjiang Medical University Affiliated Tumor Hospital, Urumqi, Xinjiang, China.
Abstract:
Triple negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer with the worst prognosis. Heterogeneous nuclear ribonucleoprotein A2/B1 (HNRNPA2B1), a member of the RNA-binding protein (RBP) hnRNPs family, is aberrantly expressed in various human cancers, serving as a marker of poor prognosis and acting as an oncogene. However, its expression, biological function, and molecular mechanism in TNBC remain unclear. In this study, we examined the expression of HNRNPA2B1 in one normal mammary epithelial cell line (MCF10A) and four TNBC cell lines (HS 578 T, BT-20, MDA-MB-468, and MDA-MB-231). We conducted in vitro and in vivo knockdown experiments to compare the growth ability, gene expression profiles, and alternative splicing patterns of TNBC cells with HNRNPA2B1 knockdown to those of control cells. Our results demonstrated that HNRNPA2B1 is overexpressed in triple-negative breast cancer tissues and cell lines. Knockdown of HNRNPA2B1 significantly inhibited proliferation and metastasis while promoting apoptosis in TNBC cells. Mechanistically, HNRNPA2B1 knockdown broadly impacted the expression and alternative splicing of genes associated with cell migration, proliferation, and apoptosis. Using Nanopore long-read sequencing, we further revealed that HNRNPA2B1 regulates gene expression in TNBC cells through the modulation of alternative polyadenylation. These findings highlight the critical role of HNRNPA2B1 in TNBC progression, providing new insights into its mechanisms and potential therapeutic applications.
Insights
Heterogeneous nuclear ribonucleoprotein A2/B1 (HNRNPA2B1) drives triple-negative breast cancer (TNBC) growth and metastasis. Inhibiting HNRNPA2B1 in TNBC cells suppressed proliferation and metastasis, offering potential therapeutic strategies.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Triple-negative breast cancer (TNBC) is an aggressive subtype with poor prognosis.
- Aberrant expression of Heterogeneous nuclear ribonucleoprotein A2/B1 (HNRNPA2B1), an RNA-binding protein, is linked to poor outcomes in various cancers.
- The role and mechanisms of HNRNPA2B1 in TNBC remain largely uncharacterized.
Purpose of the Study:
- To investigate the expression and function of HNRNPA2B1 in TNBC.
- To elucidate the molecular mechanisms by which HNRNPA2B1 influences TNBC progression.
- To assess the therapeutic potential of targeting HNRNPA2B1 in TNBC.
Main Methods:
- Examined HNRNPA2B1 expression in normal and TNBC cell lines.
- Performed in vitro and in vivo knockdown experiments of HNRNPA2B1 in TNBC cells.
- Analyzed changes in cell proliferation, metastasis, apoptosis, gene expression, and alternative splicing using various techniques, including Nanopore long-read sequencing.
Main Results:
- HNRNPA2B1 is significantly overexpressed in TNBC tissues and cell lines.
- Knockdown of HNRNPA2B1 inhibited TNBC cell proliferation and metastasis, while promoting apoptosis.
- HNRNPA2B1 knockdown altered gene expression and alternative splicing, impacting cell migration, proliferation, and apoptosis pathways.
- Nanopore sequencing revealed HNRNPA2B1 regulates gene expression via alternative polyadenylation modulation.
Conclusions:
- HNRNPA2B1 is a critical oncogene in TNBC progression.
- Targeting HNRNPA2B1 demonstrates potential for novel therapeutic strategies in TNBC.
- Understanding HNRNPA2B1's role in alternative polyadenylation provides new mechanistic insights into TNBC development.
Related Concept Videos
lncRNA - Long Non-coding RNAs
The Nucleolus
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
